---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-083559"
form_type: "8-K"
ticker: "CAPR"
cik: "0001133869"
company_name: "CAPRICOR THERAPEUTICS, INC."
filed_at: "2026-07-14T21:06:03+00:00"
generated_at: "2026-07-14T21:08:04.286176+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Capricor signs lease for 171K sq ft HQ; rent abatement, FDA approval contingency

## Summary
- Lease for 171,000 rentable sq ft at 9625 Towne Centre Dr, San Diego, as new HQ with manufacturing cleanrooms.
- Initial monthly base rent ~$958K ($5.60/sq ft), escalating 3% annually; 18-month full rent abatement then 6-month partial.
- Lease term 138 months from rent commencement; commencement tied to earlier of FDA approval satisfaction or Dec 31, 2026.
- If FDA approval of Deramiocel for Duchenne muscular dystrophy not obtained by Dec 31, 2026, either party may terminate.
- Security deposit ~$958K in cash or letter of credit; Capricor responsible for taxes, insurance, operating costs.

## SEC filing metadata
- accession: 0001104659-26-083559
- form_type: 8-K
- ticker: CAPR
- cik: 0001133869
- company_name: CAPRICOR THERAPEUTICS, INC.
- filed_at: 2026-07-14T21:06:03+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 2.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1133869/000110465926083559/0001104659-26-083559-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1133869/000110465926083559/capr-20260709x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-083559
- JSON: https://secwatch.observer/filing/0001104659-26-083559.json
- Plain text: https://secwatch.observer/filing/0001104659-26-083559.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.